A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA). (Q53673760)
Jump to navigation
Jump to search
scientific article published on 6 December 2014
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA). |
scientific article published on 6 December 2014 |
Statements
A phase II trial of paclitaxel, carboplatin, and bevacizumab in advanced and recurrent endometrial carcinoma (EMCA). (English)
1 reference
Fiona Simpkins
1 reference
Richard Drake
1 reference
Pedro F Escobar
1 reference
Benjamin Nutter
1 reference
Nabila Rasool
1 reference
Peter G Rose
1 reference
6 December 2014
1 reference
136
1 reference
240-245
1 reference
2
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference